Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 9
Out of 4,829 analysts
328
Total ratings
49.14%
Success rate
158.01%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $238.68 | +46.64% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $234.41 | +49.31% | 15 | May 2, 2025 | |
| ILMN Illumina | Maintains: Neutral | $90 → $85 | $75.76 | +12.20% | 16 | Apr 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $133.96 | +60.50% | 9 | Apr 7, 2025 | |
| BRKR Bruker | Maintains: Buy | $75 → $50 | $37.52 | +33.26% | 15 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,080.98 | +29.51% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $8.77 | +71.04% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $12.02 | +49.75% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $49.94 | +40.17% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $56.75 | +23.35% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $148.99 | +40.95% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $403.13 | +41.39% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $176.96 | +4.54% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $155 → $175 | $138.79 | +26.09% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $189.73 | +39.67% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $6.15 | +273.98% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $36.36 | +37.51% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $13.13 | +52.32% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $51.63 | +45.26% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $106.93 | +54.31% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $41.72 | +7.86% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $24.00 | +16.67% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $91.25 | +58.90% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $41.86 | +47.63% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $344.06 | -12.81% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.51 | +258.57% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.22 | +23.87% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $245.73 | +5.81% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $5.04 | +19.05% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $3.89 | +722.62% | 2 | Nov 30, 2018 |
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $238.68
Upside: +46.64%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $234.41
Upside: +49.31%
Illumina
Apr 7, 2025
Maintains: Neutral
Price Target: $90 → $85
Current: $75.76
Upside: +12.20%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $133.96
Upside: +60.50%
Bruker
Apr 7, 2025
Maintains: Buy
Price Target: $75 → $50
Current: $37.52
Upside: +33.26%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,080.98
Upside: +29.51%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $8.77
Upside: +71.04%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $12.02
Upside: +49.75%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $49.94
Upside: +40.17%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $56.75
Upside: +23.35%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $148.99
Upside: +40.95%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $403.13
Upside: +41.39%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $176.96
Upside: +4.54%
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $138.79
Upside: +26.09%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $189.73
Upside: +39.67%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $6.15
Upside: +273.98%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $36.36
Upside: +37.51%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $13.13
Upside: +52.32%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $51.63
Upside: +45.26%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $106.93
Upside: +54.31%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $41.72
Upside: +7.86%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $24.00
Upside: +16.67%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $91.25
Upside: +58.90%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $41.86
Upside: +47.63%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $344.06
Upside: -12.81%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.51
Upside: +258.57%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.22
Upside: +23.87%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $245.73
Upside: +5.81%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $5.04
Upside: +19.05%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $3.89
Upside: +722.62%